Evidence supporting our content
A working list of the trials, guidelines, and reviews we most frequently cite. This page complements the references list — see also our sources & verification page.
Randomized trials — surgery
- STAMPEDE — Bariatric surgery vs. intensive medical therapy in T2D (Schauer et al., NEJM)
- SM-BOSS — Sleeve vs. gastric bypass (Peterli et al., JAMA)
- SLEEVEPASS — Sleeve vs. gastric bypass long-term (Salminen et al., JAMA)
Randomized trials — GLP-1 medications
- STEP program — Semaglutide for weight management (Wilding et al., NEJM)
- SURMOUNT — Tirzepatide for weight management (Jastreboff et al., NEJM)
Guidelines
- ADA — Standards of Care in Diabetes (current edition)
- AACE / ACE — Obesity Clinical Practice Guidelines
- ASMBS / IFSO — 2022 Indications for Metabolic and Bariatric Surgery
- NICE — Obesity management (UK)
Dr. Ariel Ortiz Lagardere, MD, FACS, FASMBS
Bariatric & Metabolic Surgeon · Founder, Obesity Control Center
- Content reviewed
- Curated list of trials and guidelines cited across the site.
- Last reviewed
- 2026-06-01
See our medical review policy, editorial policy, and references.
Dr. Ariel Ortiz Lagardere, MD, FACS, FASMBS
Bariatric & Metabolic Surgeon · Founder, Obesity Control Center
Last reviewed: June 2026
Educational claims on this page are supported by independent guidelines, peer-reviewed evidence, and verifiable accreditation listings. See Sources & Verification and Science & Evidence.
Medical notice. This content is educational only and does not replace professional medical advice. Do not start, stop, or change GLP-1 medication without consulting your physician.